Medical Cannabis News


Lose weight with marijuana?

Thomas Clark, PhD, has always specialized in mosquitoes, but now he's being distracted by marijuana. Outside of his regular job as professor and chief of biological sciences at Indiana University, South Bend, he is increasingly called upon to lecture about the benefits of cannabis in humans — especially the potential for weed as a weight loss aid.


People opting for CBD instead of medical treatments for bipolar disorder ‘not treated at all’, says experts

CBD has become quite the medical miracle since the United States legalized hemp-derived cannabinoids and removed it from the list of Controlled Substances back in December 2018. More and more countries seem to take a step forward into a future of better medical treatments with enhanced potency to cure life threatening ailments like Cancer. 

Though many people have resorted to CBD for reducing stress, anxiety, depression, swelling, pain, inflammation and even speedy recovery from accidents, it is not established as a fact how impactful CBD really is. 


Medical marijuana vs recreational marijuana: What’s the difference?

More and more states have been legalizing marijuana in the United States for medicinal use, but only a fraction of those states have made the use of recreational marijuana legal. The majority of the people that support the legalization of marijuana are in favor for the way that it can help with many health conditions, treating pain and soothing the side effects of cancer treatment. However, there are some people that believe that using it recreationally is inappropriate, and that even allowing adults to smoke it will ultimately lead to the country’s demise.


Canopy Growth receives key extraction licence

Canopy Growth Corporation(TSX: WEED), (NYSE: CGC) (“Canopy Growth” or the “Company”) is pleased to announce that it has received a licence from Health Canada for its 


Cannabis stocks: the future is medical

For a long time, I have been down on cannabis stocks. I have looked only to their poor earnings, the hype surrounding them, and the recreational aspect of the products.

I am still not convinced that they will be able to be competitive on a recreational level due to the ease with which the product can be replicated by individuals and smaller companies as well as the moral implications of selling narcotics.

But there is one aspect of cannabis which has recently gained legitimacy in my mind, and that is the utilitarian value of their medical effects.

My relatively recent turnaround in this department has come as a result of a close friend that had developed an illness that was not responding well to conventional treatments.


Pot and your pet: Veterinarians seeing more THC toxicity in dogs

"Your dog is positive for THC, and she's really high right now."

That's something Jennifer Wright never expected to hear from the on-call veterinarian at the Animal Hospital of Cambridge.

Coco, the Wright family's nine-month-old Yorkie-Havanese cross, had been acting out of sorts that evening. 

"She was really lethargic, she picked her head up and it was wobbling," Wright said. "So I picked her up and I tried to set her down on the ground, and that's when I noticed ... her back end was sort of swaying back and forth. She looked like she was going to fall over, and she could not walk, she would not walk."

The family piled into the car and franticly tried to find a clinic that was open in the off-hours. 


Shoppers Drug Mart successfully completes phase 1 of its medical cannabis verification pilot program

Shoppers Drug Mart ("Shoppers") today announced the successful completion of Phase 1 of its blockchain-secured pilot program (the "Pilot Program") with software partner TruTrace Technologies Inc. (CSE: TTT; OTCQB: TTTSF) ("TruTrace"). The Pilot Program is specifically designed to increase transparency, interoperability and product identification within the medical cannabis industry. Shoppers has now engaged TruTrace and Deloitte Canada LLP ("Deloitte")  to execute Phase 2 of the Pilot Program, with full production and implementation of TruTrace's StrainSecure platform targeted for late November 2019.


Pure CBD oil capsules and CBD oils are top selling consumer favorites in 2019

The top selling CBD brands for the first half of 2019 are brands that feature pure CBD either in capsule form or liquid oils form that have been independently lab tested for purity and authenticity, see here


Should cannabis investors buy into the biosynthesis hype?

The cannabis space is getting interesting again ahead of the legalization of edibles and other peripheral products this fall. With Aphria rocketing on an encouraging quarterly win (and creating a much-needed tailwind for other marijuana stocks in its wake), investors are eyeing the hegemony of the fledgling sector with their appetite for risk and upside renewed.

However, one stock in particular has been grabbing the attention of pot stock believers.


Cannabis company MGC Pharmaceuticals on watch after “transformational event”

The MGC Pharmaceuticals Ltd (ASX: MXC) share price could be on the move today after the cannabis company released a late announcement on Thursday.

What did MGC Pharmaceuticals announce?

On Thursday MGC Pharmaceuticals provided an update on the planned construction of its Malta-based state-of-the-art Good Manufacturing Practice (GMP) production and research facility.

According to the release, the company has signed a long-term lease agreement on a 6,000m2 site in Malta, which was previously identified and designated to MGC Pharma by Malta Industrial Parks.


Subscribe to RSS - Medical Cannabis News